4//SEC Filing
Parini Michael 4
Accession 0001209191-21-010703
CIK 0000875320other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:15 PM ET
Size
8.8 KB
Accession
0001209191-21-010703
Insider Transaction Report
Form 4
Parini Michael
EVP & CLO
Transactions
- Sale
Common Stock
2021-02-11$211.21/sh−300$63,363→ 50,546 total - Sale
Common Stock
2021-02-11$210.43/sh−3,818$803,422→ 50,846 total - Sale
Common Stock
2021-02-11$211.97/sh−200$42,394→ 50,346 total
Footnotes (5)
- [F1]Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $210.43 (range $209.95 to $210.94).
- [F3]Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F4]Open market sales reported on this line occurred at a weighted average price of $211.21 (range $210.97 to $211.33).
- [F5]Open market sales reported on this line occurred at a weighted average price of $211.97 (range $211.97 to $211.98).
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001661567
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:15 PM ET
- Size
- 8.8 KB